How is Alzheimer's disease treated? Phase III trials of the AXS-05 are to be carried out
New medicine for incurable depression! AXS-05 significantly improves depressive symptoms and impaired function
New medicine for incurable depression! AXS-05 (right methafen/aphedone release tablets) fast
Healing Alzheimer's! FDA grants AXS-05 breakthrough drug eligibility!
As of 2020/05/28, a complete list of drugs for consistency evaluation has been published.
Treating Alzheimer's (AD) is exciting! The FDA has awarded AXS-05 (right metafen/amphetamine transfer agent) breakthrough drug qualification!
AXS-05 approved by FDA for breakthrough therapy for Alzheimer's disorder
Axsome Therapeutics Innovative Therapy AXS-05 Awarded by fda for Breakthrough Therapy
The smoking cessation drug AXS-05 reaches its main endpoint in the course of smoking cessation
Quickly improve symptoms! AXS-05 Treatment AD-Related Mania II/III Clinical End point
AXS-05 Treatment of Alzheimer's Disease-Related Intensive Phase II/III Trial Accelerated!
ASTM International Standards Organization cancels all standard meetings scheduled for April
New medicine for depression! Axsome compound drug axs-05 (dextromethorphan / bupropion release
Development of anti Ebola drug jk-05 by Sihuan pharmaceutical and Academy of Military Sciences
China's anti Ebola drug "jk-05" is expected to be put into Africa in batches
"Jk-05", an anti Ebola drug of the Academy of Military Medical Sciences, was approved by the army as a special drug
ASTM-D999 standard for simulated transport vibration table
The Ministry of agriculture of Argentina estimates that the wheat output in 2004 / 05 will be 16 million tons
Argentina's soybean harvest completed 13% in 2004 / 05
The shortage of grain supply and demand in 2004 / 05 will be relieved